Large pharmas probe takeover of Horizon Therapeutics
Bluebird Bio sells priority review voucher for $102M
Another Twitter blow to science as Musk ends COVID misinformation policy
Nimbus on cloud 9 as psoriasis data support taking rival to Bristol Myers' Sotyktu into phase 3
*please scroll down for all the latest news*
